Exelixis will shutter its facility in King of Prussia, Pennsylvania, and is laying off 130 employees companywide as the cancer specialist rightsizes its operations after a pandemic-era boom in hiring. While a company statement provided to BioSpace did not give an exact breakdown of where affected staffers are located, 71 people at the biotech’s Alameda, California, headquarters are being let go effective Oct. 27. In addition, Fierce Biotech has reported that 33 remote employees who report to California-based managers are being cut. According to the statement, Exelixis hired a significant number of employees—including many remote workers—during the pandemic and post-pandemic period to meet business needs. The biotech is now reorganizing its structure to focus largely on its Alameda operations. It expects to reopen many of the affected positions as new roles at its headquarters.
All entries for: Facility Closure
August 29, 2025
Exelixis
Facility Closure, Layoffs
Alameda, CA
1,001-5,000 employees
Disease Area: Oncology
Drug Type: Biologic, Small Molecule